This company has been marked as potentially delisted and may not be actively trading. Humanigen (HGEN) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Former Humanigen director arrested for insider tradingDecember 25, 2024 | msn.comUS says former Humanigen chief scientific officer charged with insider tradingDecember 23, 2024 | reuters.comHumanigen, Inc. (HGEN)October 10, 2024 | finance.yahoo.com0KB1.SG,0P00011RKD,0 (0KB1.SG)August 4, 2024 | ca.finance.yahoo.comHumanigen Inc (0KB2.BE)March 24, 2024 | finance.yahoo.comHumanigen Inc HGENQFebruary 6, 2024 | morningstar.comLevi & Korsinsky, LLP Notifies Shareholders of Humanigen, Inc. (HGEN) an Upcoming Claims Deadline in a Class Action SettlementJanuary 25, 2024 | markets.businessinsider.comFirm Retention Summary: HumanigenJanuary 17, 2024 | wsj.comHumanigen Downfall: FDA Rejection For COVID-19 Drug Triggers Financial Crisis, BankruptcyJanuary 5, 2024 | msn.comCOVID-19 treatment developer Humanigen files for Chapter 11 bankruptcyJanuary 4, 2024 | news.yahoo.comCovid-19 Treatment Developer Humanigen Files for BankruptcyJanuary 4, 2024 | wsj.comCOVID pick Humanigen files for bankruptcyJanuary 4, 2024 | msn.comAktueller Chart HUMANIGEN AktieDecember 9, 2023 | finanznachrichten.deHumanigen, Inc. (HGEN) stock historical prices & data – Yahoo FinanceOctober 13, 2023 | uk.finance.yahoo.comHumanigen, Inc. (HGEN) stock price, news, quote & history – Yahoo FinanceAugust 11, 2023 | uk.finance.yahoo.comHumanigen Announces First Participant Dosed in RATinG Trial of Lenzilumab for Early Treatment of Acute Graft Versus Host Disease Following Allogeneic Stem Cell TransplantationAugust 7, 2023 | finance.yahoo.comHumanigen stock removed from S&P Total Market Index as firm faces...July 30, 2023 | proactiveinvestors.comHumanigen stock removed from S&P Total Market Index as firm faces bankruptcyJuly 28, 2023 | proactiveinvestors.comHumanigen Shares Plunge 73% as Business Combination Fails, Going Concern Issues RaisedJuly 25, 2023 | marketwatch.comWhy Is Humanigen (HGEN) Stock Down 72% Today?July 25, 2023 | markets.businessinsider.comHumanigen (NASDAQ:HGEN) Nosedives with Bankruptcy Looming LargeJuly 25, 2023 | msn.comHumanigen to weigh bankruptcy as shares delist from NasdaqJuly 25, 2023 | seekingalpha.comHumanigen (HGEN) Surges on Lenzilumab Study Data for LeukemiaApril 17, 2023 | nasdaq.comHumanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of LeukemiaApril 14, 2023 | finance.yahoo.comHumanigen, Inc. (HGEN) Stock Historical Prices & Data - Yahoo FinanceDecember 20, 2022 | finance.yahoo.comHumanigen Reports Third Quarter 2022 Financial ResultsNovember 14, 2022 | finance.yahoo.comHumanigen Announces Participation and Presentation at Jefferies London Healthcare ConferenceNovember 10, 2022 | finance.yahoo.comHumanigen Announces Retention of SC&H Capital as Financial AdvisorOctober 31, 2022 | finance.yahoo.com2022-10-19 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 19, 2022 | stockhouse.comThis Addiction Drug Shows Some Potential Against Long COVID Symptoms - Humanigen (NASDAQ:HGEN), GSK (NYSE - BenzingaOctober 19, 2022 | benzinga.comCLASS ACTION UPDATE for HGEN, SQ and OPEN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Be - BenzingaOctober 19, 2022 | benzinga.comGLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Humanigen, Inc. Investors to Secure Counsel Before Important October 25 Deadline in Securities Class Action – HGEN - Business WireOctober 18, 2022 | businesswire.comROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important October 25 Deadline in Securities Class Action - HGENOctober 18, 2022 | prnewswire.comBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Coupang, Humanigen, Latch, and Azure and Encourages Investors to Contact the Firm - GuruFocus.comOctober 17, 2022 | gurufocus.comHGEN LAWSUIT ALERT: Levi & Korsinsky Notifies Humanigen, Inc. Investors of a Class Action Lawsuit and Upc - BenzingaOctober 16, 2022 | benzinga.com2022-10-15 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 15, 2022 | stockhouse.comHGEN SHAREHOLDER ALERT: Jakubo - GuruFocus.comOctober 14, 2022 | gurufocus.com2022-10-14 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 14, 2022 | stockhouse.comHGEN LAWSUIT ALERT: Levi & Kor - GuruFocus.comOctober 13, 2022 | gurufocus.comROSEN, RESPECTED INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors With Losses to Secure Counsel Bef - BenzingaOctober 13, 2022 | benzinga.com2022-10-13 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 13, 2022 | stockhouse.comHumanigen Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 25, 2022 - BenzingaOctober 12, 2022 | benzinga.comBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Coupang, - BenzingaOctober 11, 2022 | benzinga.com2022-10-09 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 10, 2022 | stockhouse.comROSEN, NATIONAL TRIAL LAWYERS, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important De - BenzingaOctober 10, 2022 | benzinga.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGEN - PR NewswireOctober 8, 2022 | prnewswire.comROSEN, GLOBAL INVESTOR COUNSEL, Encourages Humanigen, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - HGENOctober 8, 2022 | prnewswire.comHGEN.N - Humanigen Inc | Stock Price & Latest News | ReutersOctober 7, 2022 | reuters.com2022-10-06 | NDAQ:HGEN | Press Release | Humanigen Inc. - StockhouseOctober 7, 2022 | stockhouse.comBragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Stitch F - BenzingaOctober 6, 2022 | benzinga.com Remove Ads Get Humanigen News Delivered to You Automatically Sign up to receive the latest news and ratings for HGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address HGEN Media Mentions By Week HGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. HGEN News Sentiment▼0.000.61▲Average Medical News Sentiment HGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. HGEN Articles This Week▼00▲HGEN Articles Average Week Remove Ads Get Humanigen News Delivered to You Automatically Sign up to receive the latest news and ratings for HGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Alpha Tau Medical News BriaCell Therapeutics News enGene News Fortress Biotech News GeoVax Labs News Lexaria Bioscience News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:HGEN) was last updated on 4/5/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredIt’s Time to Buy Elon’s “ChatGPT Killer”Elon Musk’s new AI model is blowing everyone’s mind. It has been called “a game-changer in AI innovation”.....Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Humanigen, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Humanigen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.